HuGE Literature Finder
Records
1
-
30
| Impact of CYP2C19 and CYP2C9 gene polymorphisms on sodium valproate plasma concentration in patients with epilepsy. European journal of hospital pharmacy : science and practice 2020 Aug . Song Cangsang, Li Xingde, Mao Panpan, Song Wenbing, Liu Lu, Zhang Ya |
| Polymorphisms of vitamin K-related genes (EPHX1 and VKORC1L1) and stable warfarin doses. Gene 2017 Oct . Chung Jee-Eun, Lee Kyung Eun, Chang Byung Chul, Gwak Hye S |
| Influence of NR3C1 and VDR polymorphisms on stable warfarin dose in patients with mechanical cardiac valves. International journal of cardiology 2017 Jun 236 393-397. Lee Kyung Eun, Chung Jee Eun, Yi Boram, Cho Yoon Jeong, Kim Hyun Jeong, Lee Gwan Yung, Kim Joo Hee, Chang Byung Chul, Gwak Hye S |
| Evaluation of Concomitant Antiretrovirals and CYP2C9/CYP2C19 Polymorphisms on the Pharmacokinetics of Etravirine. Clinical pharmacokinetics 2017 05 56 (5): 525-536. Green Bruce, Crauwels Herta, Kakuda Thomas N, Vanveggel Simon, Brochot An |
| Evaluation of the pharmacokinetics of glibenclamide tablet given, off label, orally to children suffering from neonatal syndromic hyperglycemia. European journal of clinical pharmacology 2016 Aug . Bouazza Naïm, Djerada Zoubir, Gozalo Claire, Busiah Kanetee, Beltrand Jacques, Berdugo Marianne, Urien Saik, Treluyer Jean-Marc, Polak Mich |
| Population differences in S-warfarin pharmacokinetics among African Americans, Asians and whites: their influence on pharmacogenetic dosing algorithms. The pharmacogenomics journal 2016 Aug . Kubo K, Ohara M, Tachikawa M, Cavallari L H, Lee M T M, Wen M S, Scordo M G, Nutescu E A, Perera M A, Miyajima A, Kaneko N, Pengo V, Padrini R, Chen Y T, Takahashi |
| Association of Genetic Polymorphisms of CYP2C9 and VKORC1 with Bleeding Following Warfarin: A Case-Control Study. Current clinical pharmacology 2016 Jan . Thatte Urmi |
| [Population pharmacokinetic/pharmacodynamic modeling of warfarin by nonlinear mixed effects model]. Yao xue xue bao = Acta pharmaceutica Sinica 2015 Oct 50 (10): 1280-4. Lin Rong-fang, Lin Wei-wei, Wang Chang-lian, Huang Pin-fang, Fang Su-j |
| Differences in CYP2C9 Genotype and Enzyme Activity Between Swedes and Koreans of Relevance for Personalized Medicine: Role of Ethnicity, Genotype, Smoking, Age, and Sex. Omics : a journal of integrative biology 2015 May . Hatta Fazleen H M, Lundblad Mia, Ramsjo Margareta, Kang Ju-Hee, Roh Hyung-Keun, Bertilsson Leif, Eliasson Erik, Aklillu Ele |
| CYP2C19*17 affects R-warfarin plasma clearance and warfarin INR/dose ratio in patients on stable warfarin maintenance therapy. European journal of clinical pharmacology 2015 Apr 71 (4): 433-9. Chang Ming, Söderberg Mao Mao, Scordo Maria Gabriella, Tybring Gunnel, Dahl Marja-Lii |
| Individualized phenytoin therapy for Japanese pediatric patients with epilepsy based on CYP2C9 and CYP2C19 genotypes. Therapeutic drug monitoring 2015 Apr 37 (2): 229-35. Yamamoto Yoshiaki, Takahashi Yukitoshi, Imai Katsumi, Miyakawa Kou, Ikeda Hiroko, Ueda Yuki, Yamaguchi Tokito, Nasu Hirosato, Ohtani Hideyuki, Shigematsu Hideo, Kagawa Yoshiyuki, Inoue Yus |
| Effect of CYP2C9, CYP4F2 and VKORC1 genetic polymorphisms on pharmacokinetics and pharmacodynamics of mean daily maintenance dose of warfarin in Chinese patients. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2015 Mar 26 (2): 167-74. Zhuang Wenfang, Wen Wei, Xuan Binbin, Chen Yanhong, Cao Yanan, Sun Zhixin, Ma J |
| Factors influencing pharmacokinetics of warfarin in African-Americans: implications for pharmacogenetic dosing algorithms. Pharmacogenomics 2015 16 (3): 217-25. Nagai Rui, Ohara Minami, Cavallari Larisa H, Drozda Katarzyna, Patel Shitalben R, Nutescu Edith A, Perera Minoli A, Hernandez Wenndy, Kaneko Naoko, Hibiya Manabu, Takahashi Haru |
| Warfarin dosage response related pharmacogenetics in Chinese population. PloS one 2015 10 (1): e0116463. Li Siyue, Zou Yuangao, Wang Xia, Huang Xunbei, Sun Yong, Wang Yuqing, Dong Li, Jiang Ho |
| CYP2C9, VKORC1, CYP4F2, ABCB1 and F5 variants: influence on quality of long-term anticoagulation. Pharmacological reports : PR 2014 Apr 66 (2): 243-9. Nahar Risha, Saxena Renu, Deb Roumi, Parakh Rajiv, Shad Sujay, Sethi Prahlad K, Takkar Parul, Verma Ishwar |
| [Influence of warfarin related genes and non- genetic factors on administrative dose in Shanghai area]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2014 Jan 35 (1): 13-7. Zhuang Wenfang, Wu Depei, Wang Zhaoy |
| Effect of CYP2C9, VKORC1, CYP4F2 and GGCX genetic variants on warfarin maintenance dose and explicating a new pharmacogenetic algorithm in South Indian population. European journal of clinical pharmacology 2014 Jan 70 (1): 47-56. Krishna Kumar Dhakchinamoorthi, Shewade Deepak Gopal, Loriot Marie-Anne, Beaune Philippe, Balachander Jayaraman, Sai Chandran B V, Adithan Chandrasekar |
| Prediction of warfarin maintenance dose in Han Chinese patients using a mechanistic model based on genetic and non-genetic factors. Clinical pharmacokinetics 2013 Jul 52 (7): 567-81. Lu Yuan, Yang Jinbo, Zhang Haiyan, Yang J |
| Quantifying the effect of covariates on concentrations and effects of steady-state phenprocoumon using a population pharmacokinetic/pharmacodynamic model. Clinical pharmacokinetics 2013 May 52 (5): 359-71. Abduljalil Khaled, Lazar Simone, Natanzon Michael, Wu Weidong, Zadoyan Gregor, Steffens Benedict, Kohl Victoria, Mörike Klaus, Tomalik-Scharte Dorota, Stingl Julia, Schwab Matthias, Harenberg Job, Gleiter Christoph, Fuhr U |
| Population pharmacokinetics of cyclophosphamide in patients with thalassemia major undergoing HSCT. Bone marrow transplantation 2012 Sep 47 (9): 1178-85. Balasubramanian P, Desire S, Panetta J C, Lakshmi K M, Mathews V, George B, Viswabandya A, Chandy M, Krishnamoorthy R, Srivastava |
| The combined effects of clinical factors and CYP2C9 and VKORC1 gene polymorphisms on initiating warfarin treatment in patients after cardiac valve surgery. The Journal of heart valve disease 2012 Sep 21 (5): 5. Tatar?nas V, Lesauskaite V, Veikutiene A, Grybauskas P, Jakuska P, Benetis R |
| White blood cells contribute to patient-specific warfarin dose for Han Chinese. Chinese medical journal 2012 Jun 125 (11): 1960-3. Zhu Jin, Zheng Wen-Jie, Zhang Wei-Juan, Wang He-Yao, Wang Ch |
| Multivariate analysis of the relation between diet and warfarin dose. European journal of clinical pharmacology 2012 Mar 68 (3): 321-8. Rasmussen Morten Arendt, Skov Jane, Bladbjerg Else-Marie, Sidelmann Johannes J, Vamosi Marianne, Jespersen Jørg |
| A pharmacokinetic-pharmacodynamic model for predicting the impact of CYP2C9 and VKORC1 polymorphisms on fluindione and acenocoumarol during induction therapy. Clinical pharmacokinetics 2012 Jan 51 (1): 41-53. Verstuyft Céline, Delavenne Xavier, Rousseau Alexandra, Robert Annie, Tod Michel, Diquet Bertrand, Lebot Martine, Jaillon Patrice, Becquemont Laure |
| Development and comparison of a warfarin-dosing algorithm for Korean patients with atrial fibrillation. Clinical therapeutics 2011 Oct 33 (10): 1371-80. Cho Hyun-Jung, On Young-Keun, Bang Oh Young, Kim Jong-Won, Huh Wooseong, Ko Jae-Wook, Kim June Soo, Lee Soo-Yo |
| Evaluation of the effects of VKORC1 polymorphisms and haplotypes, CYP2C9 genotypes, and clinical factors on warfarin response in Sudanese patients. European journal of clinical pharmacology 2011 May . Shrif NE, Won HH, Lee ST, Park JH, Kim KK, Kim MJ, Kim S, Lee SY, Ki CS, Osman IM, Rhman EA, Ali IA, Idris MN, Kim JW |
| Contribution of 1173C > T polymorphism in the VKORC1 gene to warfarin dose requirements in Han Chinese patients receiving anticoagulation. International journal of clinical pharmacology and therapeutics 2011 Jan 49 (1): 23-9. Yang J, Huang C, Shen Z, Miao |
| Genetic factors associated with patient-specific warfarin dose in ethnic Indonesians. BMC medical genetics 2011 12 80. Suriapranata Ivet M, Tjong Wen Ye, Wang Tingliang, Utama Andi, Raharjo Sunu B, Yuniadi Yoga, Tai Susan |
| VKORC1-1639G>A, CYP2C9, EPHX1691A>G genotype, body weight, and age are important predictors for warfarin maintenance doses in patients with mechanical heart valve prostheses in southwest China. European journal of clinical pharmacology 2010 Dec 66 (12): 1217-27. Gu Qiang, Kong Yan, Schneede Jörn, Xiao Ying-Bin, Chen Lin, Zhong Qian-Jin, Wang Xue-Feng, Hao Jia, Chen Bai-Cheng, Chen Jing-J |
| Gender is an important determinant of the disposition of the loop diuretic torasemide. Journal of clinical pharmacology 2010 Feb 50 (2): 160-8. Werner Ulrike, Werner Dierk, Heinbüchner Svetlana, Graf Bernhard, Ince Hüseyin, Kische Stefan, Thürmann Petra, König Jörg, Fromm Martin F, Zolk Oliv |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jan 12, 2022
- Content source: